{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:08:35Z","timestamp":1791590915342,"version":"4.3.4"},"reference-count":213,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Bone metastases, a common and debilitating consequence of advanced cancers, involve a complex interplay between malignant cells and the bone microenvironment. Central to this interaction are interleukins (ILs), a group of cytokines with critical roles in immune modulation and inflammation. This review explores the dualistic nature of pro-inflammatory and anti-inflammatory interleukins in bone metastases, emphasizing their molecular mechanisms, pathological impacts, and therapeutic potential. Pro-inflammatory interleukins, such as IL-1, IL-6, and IL-8, have been identified as key drivers in promoting osteoclastogenesis, tumor proliferation, and angiogenesis. These cytokines create a favorable environment for cancer cell survival and bone degradation, contributing to the progression of metastatic lesions. Conversely, anti-inflammatory interleukins, including IL-4, IL-10, and IL-13, exhibit protective roles by modulating immune responses and inhibiting osteoclast activity. Understanding these opposing effects is crucial for developing targeted therapies aimed at disrupting the pathological processes in bone metastases. Key signaling pathways, including NF-\u03baB, JAK\/STAT, and MAPK, mediate the actions of these interleukins, influencing tumor cell survival, immune cell recruitment, and bone remodeling. Targeting these pathways presents promising therapeutic avenues. Current treatment strategies, such as the use of denosumab, tocilizumab, and emerging agents like bimekizumab and ANV419, highlight the potential of interleukin-targeted therapies in mitigating bone metastases. However, challenges such as therapeutic resistance, side effects, and long-term efficacy remain significant hurdles. This review also addresses the potential of interleukins as diagnostic and prognostic biomarkers, offering insights into patient stratification and personalized treatment approaches. Interleukins have multifaceted roles that depend on the context, including the environment, cell types, and cellular interactions. Despite substantial progress, gaps in research persist, particularly regarding the precise mechanisms by which interleukins influence the bone metastatic niche and their broader clinical implications. While not exhaustive, this overview underscores the critical roles of interleukins in bone metastases and highlights the need for continued research to fully elucidate their complex interactions and therapeutic potential. Addressing these gaps will be essential for advancing our understanding and treatment of bone metastases in cancer patients.<\/jats:p>","DOI":"10.3390\/ijms25158163","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T14:39:08Z","timestamp":1722004748000},"page":"8163","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Balancing the Scales: The Dual Role of Interleukins in Bone Metastatic Microenvironments"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3403-0577","authenticated-orcid":false,"given":"Ahmad","family":"Dawalibi","sequence":"first","affiliation":[{"name":"Department of Anatomy, College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal Ahmed","family":"Alosaimi","sequence":"additional","affiliation":[{"name":"College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh 11432, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9708-2111","authenticated-orcid":false,"given":"Khalid S.","family":"Mohammad","sequence":"additional","affiliation":[{"name":"Department of Anatomy, College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","article-title":"Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity","volume":"12","author":"Coleman","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Elaasser, B., Arakil, N., and Mohammad, K.S. (2024). Bridging the Gap in Understanding Bone Metastasis: A Multifaceted Perspective. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25052846"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Sethakorn, N., Heninger, E., S\u00e1nchez-de-Diego, C., Ding, A.B., Yada, R.C., Kerr, S.C., Kosoff, D., Beebe, D.J., and Lang, J.M. (2022). Advancing Treatment of Bone Metastases through Novel Translational Approaches Targeting the Bone Microenvironment. Cancers, 14.","DOI":"10.3390\/cancers14030757"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.phrs.2017.02.023","article-title":"Emerging Therapeutic Targets in Cancer Induced Bone Disease: A Focus on the Peripheral Type 2 Cannabinoid Receptor","volume":"119","author":"Marino","year":"2017","journal-title":"Pharmacol. Res."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Cersosimo, F., Lonardi, S., Bernardini, G., Telfer, B., Mandelli, G.E., Santucci, A., Vermi, W., and Giurisato, E. (2020). Tumor-Associated Macrophages in Osteosarcoma: From Mechanisms to Therapy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155207"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Salamanna, F., Borsari, V., Contartese, D., Costa, V., Giavaresi, G., and Fini, M. (2019). What Is the Role of Interleukins in Breast Cancer Bone Metastases? A Systematic Review of Preclinical and Clinical Evidence. Cancers, 11.","DOI":"10.3390\/cancers11122018"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and Cancer: Triggers, Mechanisms, and Consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Tong, Y., Cao, Y., Jin, T., Huang, Z., He, Q., and Mao, M. (2022). Role of Interleukin-1 Family in Bone Metastasis of Prostate Cancer. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.951167"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Arakil, N., Akhund, S.A., Elaasser, B., and Mohammad, K.S. (2024). Intersecting Paths: Unraveling the Complex Journey of Cancer to Bone Metastasis. Biomedicines, 12.","DOI":"10.3390\/biomedicines12051075"},{"key":"ref_10","first-page":"615","article-title":"Comprehensive Clinical Literature Review of Managing Bone Metastases in Breast Cancer: Focus on Pain and Skeletal-Related Events","volume":"27","author":"Hamash","year":"2023","journal-title":"Clin. J. Oncol. Nurs."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/PPO.0000000000000717","article-title":"Bone Metastases","volume":"30","author":"Cook","year":"2024","journal-title":"Cancer J. Sudbury Mass"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41413-023-00260-1","article-title":"Bone Serves as a Transfer Station for Secondary Dissemination of Breast Cancer","volume":"11","author":"Huang","year":"2023","journal-title":"Bone Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3892\/ol.2020.12353","article-title":"Comparison of the Clinicopathological Characteristics and Prognosis between Chinese Patients with Breast Cancer with Bone-Only and Non-Bone-Only Metastasis","volume":"20","author":"Zhang","year":"2020","journal-title":"Oncol. Lett."},{"key":"ref_14","unstructured":"Belezikian, J. (1996). Principles of Bone Biology, Elsevier. [3rd ed.]."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Granata, V., Crisafulli, L., Nastasi, C., Ficara, F., and Sobacchi, C. (2022). Bone Marrow Niches and Tumour Cells: Lights and Shadows of a Mutual Relationship. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.884024"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"R567","DOI":"10.1530\/ERC-16-0238","article-title":"The Endocrine Influence on the Bone Microenvironment in Early Breast Cancer","volume":"23","author":"Wilson","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2147\/CMAR.S162525","article-title":"Role of Key Players in Paradigm Shifts of Prostate Cancer Bone Metastasis","volume":"10","author":"Sohail","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s13402-020-00512-w","article-title":"Role of the Bone Microenvironment in Bone Metastasis of Malignant Tumors\u2014Therapeutic Implications","volume":"43","author":"Ma","year":"2020","journal-title":"Cell. Oncol. Dordr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrc.2016.44","article-title":"Bone Metastasis: The Importance of the Neighbourhood","volume":"16","author":"Croucher","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Kreps, L.M., and Addison, C.L. (2021). Targeting Intercellular Communication in the Bone Microenvironment to Prevent Disseminated Tumor Cell Escape from Dormancy and Bone Metastatic Tumor Growth. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22062911"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Russo, S., Scotto Di Carlo, F., and Gianfrancesco, F. (2022). The Osteoclast Traces the Route to Bone Tumors and Metastases. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.886305"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s13046-022-02520-0","article-title":"Osteoblasts and Osteoclasts: An Important Switch of Tumour Cell Dormancy during Bone Metastasis","volume":"41","author":"Dai","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Renema, N., Navet, B., Heymann, M.-F., Lezot, F., and Heymann, D. (2016). RANK\u2013RANKL Signalling in Cancer. Biosci. Rep., 36.","DOI":"10.1042\/BSR20160150"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.21037\/jtd-21-1502","article-title":"Bone Metastases in Non-Small Cell Lung Cancer: A Narrative Review","volume":"14","author":"Knapp","year":"2022","journal-title":"J. Thorac. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Aggarwal, B.B. (2014). Inflammation and Cancer. Advances in Experimental Medicine and Biology, Springer.","DOI":"10.1007\/978-3-0348-0837-8"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jbo.2012.11.002","article-title":"The Role of the Bone Microenvironment in Skeletal Metastasis","volume":"2","author":"Zheng","year":"2013","journal-title":"J. Bone Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/jbmr.2231","article-title":"Direct Crosstalk between Cancer and Osteoblast Lineage Cells Fuels Metastatic Growth in Bone via Auto-Amplification of IL-6 and RANKL Signaling Pathways","volume":"29","author":"Zheng","year":"2014","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, Inflammation, and Pain","volume":"45","author":"Zhang","year":"2007","journal-title":"Int. Anesthesiol. Clin."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Al-Qahtani, A.A., Alhamlan, F.S., and Al-Qahtani, A.A. (2024). Pro-Inflammatory and Anti-Inflammatory Interleukins in Infectious Diseases: A Comprehensive Review. Trop. Med. Infect. Dis., 9.","DOI":"10.3390\/tropicalmed9010013"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41590-022-01160-y","article-title":"IL-1 and IL-1ra Are Key Regulators of the Inflammatory Response to RNA Vaccines","volume":"23","author":"Tahtinen","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/cei.13316","article-title":"IL-17 and TNF-\u03b1 Co-Operation Contributes to the Proinflammatory Response of Hepatic Stellate Cells","volume":"198","author":"Beringer","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41584-018-0109-2","article-title":"Anti-Inflammatory and Immune-Regulatory Cytokines in Rheumatoid Arthritis","volume":"15","author":"Chen","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Nikovics, K., Favier, A.-L., Rocher, M., Mayinga, C., Gomez, J., Dufour-Gaume, F., and Riccobono, D. (2023). In Situ Identification of Both IL-4 and IL-10 Cytokine-Receptor Interactions during Tissue Regeneration. Cells, 12.","DOI":"10.20944\/preprints202304.0741.v1"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Soliman, A.M., and Barreda, D.R. (2022). Acute Inflammation in Tissue Healing. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24010641"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41568-021-00363-z","article-title":"Interleukins in Cancer: From Biology to Therapy","volume":"21","author":"Briukhovetska","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/imr.12606","article-title":"The Family of the Interleukin-1 Receptors","volume":"281","author":"Boraschi","year":"2018","journal-title":"Immunol. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.biochi.2015.11.005","article-title":"Modular Organization of Interleukin-6 and Interleukin-11 \u03b1-Receptors","volume":"119","author":"Nitz","year":"2015","journal-title":"Biochimie"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/sita.200300023","article-title":"Interleukin-4- and Interleukin-13 Receptors Trigger Distinct JAK\/STAT Activation Patterns in Mouse Lymphocytes","volume":"3","author":"Friedrich","year":"2003","journal-title":"Signal Transduct."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2249.1992.tb07922.x","article-title":"Cytokine Receptors: Structure and Signal Transduction","volume":"90","author":"Foxwell","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/imr.13230","article-title":"Engineering the IL-4\/IL-13 Axis for Targeted Immune Modulation","volume":"320","author":"Bernstein","year":"2023","journal-title":"Immunol. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1126\/science.270.5243.1845","article-title":"Role of NK1.1 + T Cells in a T H 2 Response and in Immunoglobulin E Production","volume":"270","author":"Yoshimoto","year":"1995","journal-title":"Science"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature08636","article-title":"Innate Production of TH2 Cytokines by Adipose Tissue-Associated c-Kit+Sca-1+ Lymphoid Cells","volume":"463","author":"Moro","year":"2010","journal-title":"Nature"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.4049\/jimmunol.155.6.3234","article-title":"Distinct Immunohistochemical Localization of IL-4 in Human Inflamed Airway Tissues. IL-4 Is Localized to Eosinophils in Vivo and Is Released by Peripheral Blood Eosinophils","volume":"155","author":"Nonaka","year":"1995","journal-title":"J. Immunol. Baltim."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.12703\/r\/10-71","article-title":"Recent Advances in Understanding the Role of IL-4 Signaling","volume":"10","author":"Keegan","year":"2021","journal-title":"Fac. Rev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/eji.202149674","article-title":"IL-3 Regulates the Differentiation of Pathogenic Th17 Cells","volume":"52","author":"Rani","year":"2022","journal-title":"Eur. J. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Yuan, L., Li, Y., Liu, D., Zhang, H., Yang, J., Shen, H., Xia, L., Yao, L., and Lu, J. (2024). Interleukin-35 Protein Inhibits Osteoclastogenesis and Attenuates Collagen-Induced Arthritis in Mice. J. Cell. Physiol.","DOI":"10.1002\/jcp.31231"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Han, Y., Gao, H., Gan, X., Liu, J., Bao, C., and He, C. (2023). Roles of IL-11 in the Regulation of Bone Metabolism. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1290130"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1302\/2046-3758.1211.BJR-2023-0101.R1","article-title":"Interleukin-19 Promotes Bone Resorption by Suppressing Osteoprotegerin Expression in BMSCs in a Lipopolysaccharide-Induced Bone Loss Mouse Model","volume":"12","author":"Dai","year":"2023","journal-title":"Bone Jt. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/bbb\/zbad103","article-title":"Interleukin-21 Knockout Reduces Bone Loss in Ovariectomized Mice by Inhibiting Osteoclastogenesis","volume":"87","author":"Hou","year":"2023","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"ref_50","first-page":"802","article-title":"Exercise, Interleukins and Bone Homeostasis","volume":"3","year":"2016","journal-title":"Integr. Mol. Med."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Haider, M.-T., Ridlmaier, N., Smit, D.J., and Taipaleenm\u00e4ki, H. (2021). Interleukins as Mediators of the Tumor Cell\u2014Bone Cell Crosstalk during the Initiation of Breast Cancer Bone Metastasis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22062898"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Murakami, T., Nakaminami, Y., Takahata, Y., Hata, K., and Nishimura, R. (2022). Activation and Function of NLRP3 Inflammasome in Bone and Joint-Related Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105365"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.4049\/jimmunol.0803007","article-title":"The Mechanism of Osteoclast Differentiation Induced by IL-1","volume":"183","author":"Kim","year":"2009","journal-title":"J. Immunol. Baltim."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/intimm\/dxq431","article-title":"IL-1 Plays an Important Role in the Bone Metabolism under Physiological Conditions","volume":"22","author":"Lee","year":"2010","journal-title":"Int. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s11914-022-00729-8","article-title":"Inflammasomes and the IL-1 Family in Bone Homeostasis and Disease","volume":"20","author":"Tseng","year":"2022","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Landuzzi, L., Ruzzi, F., Pellegrini, E., Lollini, P.-L., Scotlandi, K., and Manara, M.C. (2024). IL-1 Family Members in Bone Sarcomas. Cells, 13.","DOI":"10.3390\/cells13030233"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s002239900715","article-title":"Immunohistochemical Localization of Selected Early Response Genes Expressed in Trabecular Bone of Young Rats given hPTH 1-34","volume":"65","author":"Liang","year":"1999","journal-title":"Calcif. Tissue Int."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.4049\/jimmunol.145.10.3297","article-title":"IL-6 Is Produced by Osteoblasts and Induces Bone Resorption","volume":"145","author":"Ishimi","year":"1990","journal-title":"J. Immunol. Baltim."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"7102","DOI":"10.4049\/jimmunol.180.11.7102","article-title":"Cutting Edge: Soluble IL-6R Is Produced by IL-6R Ectodomain Shedding in Activated CD4 T Cells","volume":"180","author":"Briso","year":"2008","journal-title":"J. Immunol. Baltim."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.transproceed.2017.07.005","article-title":"Effects of Cyclosporine, Tacrolimus, and Rapamycin on Osteoblasts","volume":"49","author":"Rubert","year":"2017","journal-title":"Transplant. Proc."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI119821","article-title":"Retrograde Inflammatory Signaling from Neutrophils to Endothelial Cells by Soluble Interleukin-6 Receptor Alpha","volume":"100","author":"Modur","year":"1997","journal-title":"J. Clin. Investig."},{"key":"ref_62","first-page":"177","article-title":"Clinical Significance of Interleukin (IL)-6 in Cancer Metastasis to Bone: Potential of Anti-IL-6 Therapies","volume":"3","author":"Tawara","year":"2011","journal-title":"Cancer Manag. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0083-6729(06)74014-6","article-title":"The Role of the Interleukin-6\/Gp130 Signaling Pathway in Bone Metabolism","volume":"74","author":"Liu","year":"2006","journal-title":"Vitam. Horm."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"41411","DOI":"10.1038\/srep41411","article-title":"Combination of IL-6 and sIL-6R Differentially Regulate Varying Levels of RANKL-Induced Osteoclastogenesis through NF-\u03baB, ERK and JNK Signaling Pathways","volume":"7","author":"Feng","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10735-022-10077-7","article-title":"IL-6 Promotes Low Concentration of RANKL-Induced Osteoclastic Differentiation by Mouse BMMs through Trans-Signaling Pathway","volume":"53","author":"Feng","year":"2022","journal-title":"J. Mol. Histol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"50200","DOI":"10.1039\/C7RA09308J","article-title":"Osteocytes Regulate Osteoblast Differentiation and Osteoclast Activity through Interleukin-6 under Mechanical Loading","volume":"7","author":"Hao","year":"2017","journal-title":"RSC Adv."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Kitaura, H., Marahleh, A., Ohori, F., Noguchi, T., Shen, W.-R., Qi, J., Nara, Y., Pramusita, A., Kinjo, R., and Mizoguchi, I. (2020). Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21145169"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/0022034514522485","article-title":"IL-6 Alters Osteocyte Signaling toward Osteoblasts but Not Osteoclasts","volume":"93","author":"Bakker","year":"2014","journal-title":"J. Dent. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bone.2018.04.015","article-title":"IL-6 Trans-Signalling Mediates Trabecular, but Not Cortical, Bone Loss after Ovariectomy","volume":"112","author":"Lazzaro","year":"2018","journal-title":"Bone"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41419-017-0126-0","article-title":"IL-6 Potentiates BMP-2-Induced Osteogenesis and Adipogenesis via Two Different BMPR1A-Mediated Pathways","volume":"9","author":"Huang","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Tang, H., Zhu, S., Chen, K., Yuan, S., Hu, J., and Wang, H. (2023). IL-17A Regulates Autophagy and Promotes Osteoclast Differentiation through the ERK\/mTOR\/Beclin1 Pathway. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0281845"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Widjaja, A.A., Chothani, S., Viswanathan, S., Goh, J.W.T., Lim, W.-W., and Cook, S.A. (2022). IL11 Stimulates IL33 Expression and Proinflammatory Fibroblast Activation across Tissues. Int. J. Mol. Sci., 23.","DOI":"10.1101\/2022.07.08.499236"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"McCoy, E.M., Hong, H., Pruitt, H.C., and Feng, X. (2013). IL-11 Produced by Breast Cancer Cells Augments Osteoclastogenesis by Sustaining the Pool of Osteoclast Progenitor Cells. BMC Cancer, 13.","DOI":"10.1186\/1471-2407-13-16"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1210\/endo.139.11.6433","article-title":"Osteotropic Agents Regulate the Expression of Osteoclast Differentiation Factor and Osteoprotegerin in Osteoblastic Stromal Cells","volume":"139","author":"Horwood","year":"1998","journal-title":"Endocrinology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1084\/jem.183.6.2581","article-title":"The Role of Gp130-Mediated Signals in Osteoclast Development: Regulation of Interleukin 11 Production by Osteoblasts and Distribution of Its Receptor in Bone Marrow Cultures","volume":"183","author":"Romas","year":"1996","journal-title":"J. Exp. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/jbmr.1506","article-title":"Sustained RANKL Response to Parathyroid Hormone in Oncostatin M Receptor-Deficient Osteoblasts Converts Anabolic Treatment to a Catabolic Effect in Vivo","volume":"27","author":"Walker","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1002\/jcb.23269","article-title":"Interleukin-4 Inhibits RANKL-Induced NFATc1 Expression via STAT6: A Novel Mechanism Mediating Its Blockade of Osteoclastogenesis","volume":"112","author":"Cheng","year":"2011","journal-title":"J. Cell. Biochem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1002\/jcb.26370","article-title":"Naringenin Inhibits Osteoclastogenesis through Modulation of Helper T Cells-Secreted IL-4","volume":"119","author":"Wang","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.4049\/jimmunol.1002628","article-title":"NF-\u03baB Signaling Participates in Both RANKL- and IL-4-Induced Macrophage Fusion: Receptor Cross-Talk Leads to Alterations in NF-\u03baB Pathways","volume":"187","author":"Yu","year":"2011","journal-title":"J. Immunol. Baltim."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1159\/000374026","article-title":"IL-4 Modulates Macrophage Polarization in Ankylosing Spondylitis","volume":"35","author":"Lin","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s00198-015-3474-6","article-title":"IL-4 Administration Exerts Preventive Effects via Suppression of Underlying Inflammation and TNF-\u03b1-Induced Apoptosis in Steroid-Induced Osteonecrosis","volume":"27","author":"Wu","year":"2016","journal-title":"Osteoporos. Int."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Zhang, Q., Chen, B., Yan, F., Guo, J., Zhu, X., Ma, S., and Yang, W. (2014). Interleukin-10 Inhibits Bone Resorption: A Potential Therapeutic Strategy in Periodontitis and Other Bone Loss Diseases. BioMed Res. Int., 2014.","DOI":"10.1155\/2014\/284836"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.4049\/jimmunol.0804165","article-title":"IL-10 Suppresses Calcium-Mediated Costimulation of Receptor Activator NF-Kappa B Signaling during Human Osteoclast Differentiation by Inhibiting TREM-2 Expression","volume":"183","author":"Ji","year":"2009","journal-title":"J. Immunol. Baltim."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/jcmm.14832","article-title":"IL-10 Induces MC3T3-E1 Cells Differentiation towards Osteoblastic Fate in Murine Model","volume":"24","author":"Xiong","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Fujioka, K., Kishida, T., Kukida, Y., Nagahara, H., Fujii, W., Murakami, K., Seno, T., Yamamoto, A., Kohno, M., and Mazda, O. (2014). SAT0562 Directly Reprogrammed Osteoblasts Genetically Engineered to Produce Interleukin-10 Significantly Suppress Osteoclastgenesis. Ann. Rheum. Dis., 73.","DOI":"10.1136\/annrheumdis-2014-eular.2247"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e12874","DOI":"10.1111\/sji.12874","article-title":"Interleukin-20 Differentially Regulates Bone Mesenchymal Stem Cell Activities in RANKL-induced Osteoclastogenesis through the OPG\/RANKL\/RANK Axis and the NF-\u03baB, MAPK and AKT Signalling Pathways","volume":"91","author":"Meng","year":"2020","journal-title":"Scand. J. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Zhang, H., Li, Y., Yuan, L., Yao, L., Yang, J., Xia, L., Shen, H., and Lu, J. (2021). Interleukin-35 Is Involved in Angiogenesis\/Bone Remodeling Coupling Through T Helper 17\/Interleukin-17 Axis. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.642676"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"148","DOI":"10.5114\/ceji.2018.77384","article-title":"IL-35 Inhibits Human Osteoclastogenesis from Monocytes Induced by Receptor-Activator of NF-\u03baB Ligand","volume":"43","author":"Yago","year":"2018","journal-title":"Cent. Eur. J. Immunol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s10753-022-01749-3","article-title":"Interleukin-35 Promote Osteogenesis and Inhibit Adipogenesis: Role of Wnt\/\u03b2-Catenin and PPAR\u03b3 Signaling Pathways","volume":"46","author":"Li","year":"2023","journal-title":"Inflammation"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1006\/cyto.2000.0747","article-title":"Gp130 Cytokine Family and Bone Cells","volume":"12","author":"Heymann","year":"2000","journal-title":"Cytokine"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cytogfr.2008.11.004","article-title":"The Dual Role of IL-6-Type Cytokines on Bone Remodeling and Bone Tumors","volume":"20","author":"Blanchard","year":"2009","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Kim, S.K., and Cho, S.W. (2022). The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.868695"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"112019","DOI":"10.1016\/j.intimp.2024.112019","article-title":"Modulatory Effect of Interleukin-2 Loaded Chitosan Nano Sphere on Regulatory T Cell Activity in Streptozotocin-Induced Diabetic Mice","volume":"132","author":"Aboelnazar","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Kim, N., Yi, E., Lee, E., Park, H.J., and Kim, H.S. (2024). Interleukin-2 Is Required for NKp30-Dependent NK Cell Cytotoxicity by Preferentially Regulating NKp30 Expression. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1388018"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/1547691X.2017.1404662","article-title":"Vanadium Pentoxide Increased PTEN and Decreased SHP1 Expression in NK-92MI Cells, Affecting PI3K-AKT-mTOR and Ras-MAPK Pathways","volume":"15","author":"Diaz","year":"2018","journal-title":"J. Immunotoxicol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s13287-023-03516-z","article-title":"ADSC Secretome Constrains NK Cell Activity by Attenuating IL-2-Mediated JAK-STAT and AKT Signaling Pathway via Upregulation of CIS and DUSP4","volume":"14","author":"Ko","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.immuni.2024.02.001","article-title":"Interleukin-2 Signaling in the Regulation of T Cell Biology in Autoimmunity and Cancer","volume":"57","author":"Shouse","year":"2024","journal-title":"Immunity"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Cheng, M.L., and Fong, L. (2014). Effects of RANKL-Targeted Therapy in Immunity and Cancer. Front. Oncol., 3.","DOI":"10.3389\/fonc.2013.00329"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.7150\/jca.21780","article-title":"Cellular Interactions in the Tumor Microenvironment: The Role of Secretome","volume":"10","author":"Domingos","year":"2019","journal-title":"J. Cancer"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"He, N., and Jiang, J. (2022). Contribution of Immune Cells to Bone Metastasis Pathogenesis. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.1019864"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1017\/erm.2022.4","article-title":"IL-1\u03b2 in Breast Cancer Bone Metastasis","volume":"24","author":"Zhou","year":"2022","journal-title":"Expert Rev. Mol. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41523-021-00305-w","article-title":"IL-1B Drives Opposing Responses in Primary Tumours and Bone Metastases; Harnessing Combination Therapies to Improve Outcome in Breast Cancer","volume":"7","author":"Tulotta","year":"2021","journal-title":"Npj Breast Cancer"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s40001-023-01083-w","article-title":"Metastasis of Breast Cancer to Bones Alters the Tumor Immune Microenvironment","volume":"28","author":"Chao","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2155-9899.1000329","article-title":"Interleukin-4 Expressed By Neoplastic Cells Provokes an Anti-Metastatic Myeloid Immune Response","volume":"6","author":"Zhang","year":"2015","journal-title":"J. Clin. Cell. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00262-017-2043-6","article-title":"IL-4 Blockade Alters the Tumor Microenvironment and Augments the Response to Cancer Immunotherapy in a Mouse Model","volume":"66","author":"Ito","year":"2017","journal-title":"Cancer Immunol. Immunother. CII"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Cheng, X., and Wang, Z. (2021). Immune Modulation of Metastatic Niche Formation in the Bone. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.765994"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Lee, H.-M., Lee, H.-J., and Chang, J.-E. (2022). Inflammatory Cytokine: An Attractive Target for Cancer Treatment. Biomedicines, 10.","DOI":"10.3390\/biomedicines10092116"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Wang, W., Dong, G., Yang, Z., Li, S., Li, J., Wang, L., Zhu, Q., and Wang, Y. (2024). Single-Cell Analysis of Tumor Microenvironment and Cell Adhesion Reveals That Interleukin-1 Beta Promotes Cancer Cell Proliferation in Breast Cancer. Anim. Models Exp. Med.","DOI":"10.1002\/ame2.12445"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Song, M., Tang, Y., Cao, K., Qi, L., and Xie, K. (2024). Unveiling the Role of Interleukin-6 in Pancreatic Cancer Occurrence and Progression. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1408312"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.ejca.2010.02.026","article-title":"Interleukin-6 in Bone Metastasis and Cancer Progression","volume":"46","author":"Ara","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1017\/erm.2023.14","article-title":"Inflammasomes in Breast Cancer: The Ignition Spark of Progression and Resistance?","volume":"25","author":"Elgohary","year":"2023","journal-title":"Expert Rev. Mol. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/pros.10238","article-title":"Expression and Function of Pro-inflammatory Interleukin IL-17 and IL-17 Receptor in Normal, Benign Hyperplastic, and Malignant Prostate","volume":"56","author":"Steiner","year":"2003","journal-title":"Prostate"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Maroni, P., Bendinelli, P., Ferraretto, A., and Lombardi, G. (2021). Interleukin 11 (IL-11): Role(s) in Breast Cancer Bone Metastases. Biomedicines, 9.","DOI":"10.3390\/biomedicines9060659"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/cmi.2010.21","article-title":"Interleukin-17 and Its Expanding Biological Functions","volume":"7","author":"Xu","year":"2010","journal-title":"Cell. Mol. Immunol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nrc3125","article-title":"Unravelling the Complexity of Metastasis\u2014Molecular Understanding and Targeted Therapies","volume":"11","author":"Sethi","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1152\/physrev.00012.2019","article-title":"Bone Metastasis: Mechanisms, Therapies, and Biomarkers","volume":"101","author":"Coleman","year":"2021","journal-title":"Physiol. Rev."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1158\/1078-0432.CCR-18-2202","article-title":"Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment","volume":"25","author":"Tulotta","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1038\/s41467-019-12807-0","article-title":"Microenvironmental IL1\u03b2 Promotes Breast Cancer Metastatic Colonisation in the Bone via Activation of Wnt Signalling","volume":"10","author":"Eyre","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"75571","DOI":"10.18632\/oncotarget.12289","article-title":"IL-1 Drives Breast Cancer Growth and Bone Metastasis in vivo","volume":"7","author":"Holen","year":"2016","journal-title":"Oncotarget"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Wang, H., Tang, H., Yuan, S., Liang, C., Li, Y., Zhu, S., and Chen, K. (2024). IL-17A Deficiency Inhibits Lung Cancer-Induced Osteoclastogenesis by Promoting Apoptosis of Osteoclast Precursor Cells. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0299028"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1177\/153303460400300501","article-title":"Serum Interleukin-8 Is Elevated in Men with Prostate Cancer and Bone Metastases","volume":"3","author":"Lehrer","year":"2004","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1158\/0008-5472.CAN-05-2630","article-title":"Tumor-Derived Interleukin-8 Stimulates Osteolysis Independent of the Receptor Activator of Nuclear Factor-\u03baB Ligand Pathway","volume":"65","author":"Bendre","year":"2005","journal-title":"Cancer Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10549-011-1855-x","article-title":"Role of Interleukin-10 in Breast Cancer","volume":"133","author":"Hamidullah","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Fan, Y.-C., Chen, W.-Y., Lee, K.-D., and Tsai, Y.-C. (2020). Tumor-Infiltrating Leukocytes Suppress Local Inflammation Via Interleukin-1 Receptor Antagonist in a Syngeneic Prostate Cancer Model. Biology, 9.","DOI":"10.3390\/biology9040067"},{"key":"ref_125","first-page":"3503","article-title":"Interleukin 4 Receptor on Human Lung Cancer: A Molecular Target for Cytotoxin Therapy","volume":"8","author":"Kawakami","year":"2002","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41586-023-06797-9","article-title":"An IL-4 Signalling Axis in Bone Marrow Drives pro-Tumorigenic Myelopoiesis","volume":"625","author":"LaMarche","year":"2024","journal-title":"Nature"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1146\/annurev-immunol-032414-112134","article-title":"The Immunobiology of Interleukin-27","volume":"33","author":"Yoshida","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/glia.22948","article-title":"Production of IL-27 in Multiple Sclerosis Lesions by Astrocytes and Myeloid Cells: Modulation of Local Immune Responses","volume":"64","author":"Deblois","year":"2016","journal-title":"Glia"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1158\/1078-0432.CCR-17-1847","article-title":"Activation of 4-1BB on Liver Myeloid Cells Triggers Hepatitis via an Interleukin-27-Dependent Pathway","volume":"24","author":"Bartkowiak","year":"2018","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s13046-023-02902-y","article-title":"Interleukin-30 Subverts Prostate Cancer-Endothelium Crosstalk by Fostering Angiogenesis and Activating Immunoregulatory and Oncogenic Signaling Pathways","volume":"42","author":"Ciummo","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Peluzzo, A.M., and Autieri, M.V. (2022). Challenging the Paradigm: Anti-Inflammatory Interleukins and Angiogenesis. Cells, 11.","DOI":"10.3390\/cells11030587"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"917","DOI":"10.4049\/jimmunol.175.2.917","article-title":"IL-4 Inhibits Bone-Resorbing Activity of Mature Osteoclasts by Affecting NF-\u03baB and Ca2+ Signaling","volume":"175","author":"Mangashetti","year":"2005","journal-title":"J. Immunol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1359\/jbmr.080203","article-title":"Interleukin-4 and Interleukin-13 Stimulate the Osteoclast Inhibitor Osteoprotegerin by Human Endothelial Cells through the STAT6 Pathway","volume":"23","author":"Stein","year":"2008","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s10020-021-00411-2","article-title":"IL4\/IL4R Signaling Promotes the Osteolysis in Metastatic Bone of CRC through Regulating the Proliferation of Osteoclast Precursors","volume":"27","author":"Jin","year":"2021","journal-title":"Mol. Med. Camb. Mass"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e09167","DOI":"10.1016\/j.heliyon.2022.e09167","article-title":"Natural Killer Cells Activity against Multiple Myeloma Cells Is Modulated by Osteoblast-Induced IL-6 and IL-10 Production","volume":"8","author":"Uhl","year":"2022","journal-title":"Heliyon"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1158\/0008-5472.CAN-17-3117","article-title":"Interleukin-30\/IL27p28 Shapes Prostate Cancer Stem-like Cell Behavior and Is Critical for Tumor Onset and Metastasization","volume":"78","author":"Sorrentino","year":"2018","journal-title":"Cancer Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13045-022-01357-6","article-title":"CRISPR\/Cas9-Mediated Deletion of Interleukin-30 Suppresses IGF1 and CXCL5 and Boosts SOCS3 Reducing Prostate Cancer Growth and Mortality","volume":"15","author":"Sorrentino","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Di Pompo, G., Errani, C., Gillies, R., Mercatali, L., Ibrahim, T., Tamanti, J., Baldini, N., and Avnet, S. (2021). Acid-Induced Inflammatory Cytokines in Osteoblasts: A Guided Path to Osteolysis in Bone Metastasis. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.678532"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03baB in Biology and Targeted Therapy: New Insights and Translational Implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1042\/BCJ20210139","article-title":"Inhibitory Feedback Control of NF-\u03baB Signalling in Health and Disease","volume":"478","author":"Prescott","year":"2021","journal-title":"Biochem. J."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Deka, K., and Li, Y. (2023). Transcriptional Regulation during Aberrant Activation of NF-\u03baB Signalling in Cancer. Cells, 12.","DOI":"10.3390\/cells12050788"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.semcancer.2021.07.015","article-title":"Long Non-Coding RNAs Regulated NF-\u03baB Signaling in Cancer Metastasis: Micromanaging by Not so Small Non-Coding RNAs","volume":"85","author":"Ahmad","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.it.2022.11.005","article-title":"NF-\u03baB Dynamics in the Language of Immune Cells","volume":"44","author":"Aqdas","year":"2023","journal-title":"Trends Immunol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"eaax7195","DOI":"10.1126\/scisignal.aax7195","article-title":"Integrative Analysis Suggests Cell Type-Specific Decoding of NF-\u03baB Dynamics","volume":"13","author":"Martin","year":"2020","journal-title":"Sci. Signal."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Zhang, L., and Bonomi, P.D. (2024). Immune System Disorder and Cancer-Associated Cachexia. Cancers, 16.","DOI":"10.20944\/preprints202404.0796.v1"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41419-024-06559-z","article-title":"Cellular Heterogeneity in TNF\/TNFR1 Signalling: Live Cell Imaging of Cell Fate Decisions in Single Cells","volume":"15","author":"Preedy","year":"2024","journal-title":"Cell Death Dis."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Somm, E., and Jornayvaz, F.R. (2022). Interleukin-18 in Metabolism: From Mice Physiology to Human Diseases. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.971745"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"8293921","DOI":"10.1155\/2020\/8293921","article-title":"The Role of Inflammation in the Pathogenesis of Osteoarthritis","volume":"2020","author":"Chow","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/bjd.21677","article-title":"Biomarkers of Systemic Treatment Response in People with Psoriasis: A Scoping Review","volume":"187","author":"Corbett","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3803\/EnM.2015.30.1.35","article-title":"NF-\u03baB-Mediated Regulation of Osteoclastogenesis","volume":"30","author":"Boyce","year":"2015","journal-title":"Endocrinol. Metab."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"113978","DOI":"10.1016\/j.yexcr.2024.113978","article-title":"RANK\/RANKL Axis Promotes Migration, Invasion, and Metastasis of Osteosarcoma via Activating NF-\u03baB Pathway","volume":"436","author":"Takeda","year":"2024","journal-title":"Exp. Cell Res."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Bousoik, E., and Montazeri Aliabadi, H. (2018). \u201cDo We Know Jack\u201d About JAK? A Closer Look at JAK\/STAT Signaling Pathway. Front. Oncol., 8.","DOI":"10.3389\/fonc.2018.00287"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"6618924","DOI":"10.1155\/2021\/6618924","article-title":"Mucosal Epithelial Jak Kinases in Health and Diseases","volume":"2021","author":"Kumar","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Fasouli, E.S., and Katsantoni, E. (2021). JAK-STAT in Early Hematopoiesis and Leukemia. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.669363"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Zhang, L., Li, J., Wang, Q., Meng, G., Lv, X., Zhou, H., Li, W., and Zhang, J. (2017). The Relationship between microRNAs and the STAT3-Related Signaling Pathway in Cancer. Tumour Biol. J. Int. Soc. Oncodev. Biol. Med., 39.","DOI":"10.1177\/1010428317719869"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","article-title":"Evolving Cognition of the JAK-STAT Signaling Pathway: Autoimmune Disorders and Cancer","volume":"8","author":"Xue","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/pro.3519","article-title":"The Molecular Details of Cytokine Signaling via the JAK\/STAT Pathway","volume":"27","author":"Morris","year":"2018","journal-title":"Protein Sci."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT Signaling Pathway: From Bench to Clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41416-022-01853-z","article-title":"STAT1 Is Regulated by TRIM24 and Promotes Immunosuppression in Head and Neck Squamous Carcinoma Cells, but Enhances T Cell Antitumour Immunity in the Tumour Microenvironment","volume":"127","author":"Anderson","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Gargalionis, A.N., Papavassiliou, K.A., and Papavassiliou, A.G. (2021). Targeting STAT3 Signaling Pathway in Colorectal Cancer. Biomedicines, 9.","DOI":"10.3390\/biomedicines9081016"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Damerau, A., Gaber, T., Ohrndorf, S., and Hoff, P. (2020). JAK\/STAT Activation: A General Mechanism for Bone Development, Homeostasis, and Regeneration. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21239004"},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Huang, B., Lang, X., and Li, X. (2022). The Role of IL-6\/JAK2\/STAT3 Signaling Pathway in Cancers. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.1023177"},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Godoi, M.A., Camilli, A.C., Gonzales, K.G.A., Costa, V.B., Papathanasiou, E., Leite, F.R.M., and Guimar\u00e3es-Stabili, M.R. (2023). JAK\/STAT as a Potential Therapeutic Target for Osteolytic Diseases. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241210290"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1096\/fj.99-1003rev","article-title":"The Soluble Interleukin 6 Receptor: Mechanisms of Production and Implications in Disease","volume":"15","author":"Jones","year":"2001","journal-title":"FASEB J."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s11912-024-01515-8","article-title":"An Update on the Management of Bone Metastases","volume":"26","author":"Grosinger","year":"2024","journal-title":"Curr. Oncol. Rep."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/08830185.2014.938325","article-title":"Tocilizumab, a Humanized Anti-IL-6R Antibody, as an Emerging Therapeutic Option for Rheumatoid Arthritis: Molecular and Cellular Mechanistic Insights","volume":"34","author":"Hashizume","year":"2015","journal-title":"Int. Rev. Immunol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.semarthrit.2017.10.022","article-title":"The Combination of IL-6 and Its Soluble Receptor Is Associated with the Response of Rheumatoid Arthritis Patients to Tocilizumab","volume":"47","author":"Ortiz","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s12282-018-0853-9","article-title":"Interleukin-6 Receptor Inhibitor Suppresses Bone Metastases in a Breast Cancer Cell Line","volume":"25","author":"Wakabayashi","year":"2018","journal-title":"Breast Cancer Tokyo Jpn."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.2147\/DDDT.S86438","article-title":"Siltuximab (CNTO 328): A Promising Option for Human Malignancies","volume":"9","author":"Chen","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-11-0945","article-title":"Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer","volume":"17","author":"Coward","year":"2011","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1016\/S0140-6736(24)00101-6","article-title":"Efficacy and Safety of Bimekizumab in Patients with Moderate-to-Severe Hidradenitis Suppurativa (BE HEARD I and BE HEARD II): Two 48-Week, Randomised, Double-Blind, Placebo-Controlled, Multicentre Phase 3 Trials","volume":"403","author":"Kimball","year":"2024","journal-title":"Lancet"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"e001306","DOI":"10.1136\/rmdopen-2020-001306","article-title":"Dual Neutralisation of IL-17F and IL-17A with Bimekizumab Blocks Inflammation-Driven Osteogenic Differentiation of Human Periosteal Cells","volume":"6","author":"Shah","year":"2020","journal-title":"RMD Open"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/annrheumdis-2020-216980","article-title":"Dual Neutralisation of Interleukin-17A and Interleukin-17F with Bimekizumab in Patients with Active Ankylosing Spondylitis: Results from a 48-Week Phase IIb, Randomised, Double-Blind, Placebo-Controlled, Dose-Ranging Study","volume":"79","author":"Gensler","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s00198-017-4012-5","article-title":"Functional Block of IL-17 Cytokine Promotes Bone Healing by Augmenting FOXO1 and ATF4 Activity in Cortical Bone Defect Model","volume":"28","author":"Dixit","year":"2017","journal-title":"Osteoporos. Int."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"e21552","DOI":"10.1200\/JCO.2022.40.16_suppl.e21552","article-title":"A Phase I\/II Study of ANV419, a Selective IL-2R-Beta-Gamma Targeted Antibody-IL-2 Fusion Protein, in Patients with Advanced Solid Tumors","volume":"40","author":"Alonso","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"e008847","DOI":"10.1136\/jitc-2024-008847","article-title":"Phase 1 First-in-Human Dose-Escalation Study of ANV419 in Patients with Relapsed\/Refractory Advanced Solid Tumors","volume":"12","author":"Mathiot","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrd3800","article-title":"Treating Inflammation by Blocking Interleukin-1 in a Broad Spectrum of Diseases","volume":"11","author":"Dinarello","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/phar.1265","article-title":"Role of Interleukin-1 Inhibitors in the Management of Gout","volume":"33","author":"Tran","year":"2013","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s40259-013-0037-2","article-title":"Canakinumab: A Guide to Its Use in Acute Gouty Arthritis Flares","volume":"27","year":"2013","journal-title":"BioDrugs"},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Zhou, J., Down, J.M., George, C.N., Murphy, J., Lefley, D.V., Tulotta, C., Alsharif, M.A., Leach, M., and Ottewell, P.D. (2022). Novel Methods of Targeting IL-1 Signalling for the Treatment of Breast Cancer Bone Metastasis. Cancers, 14.","DOI":"10.3390\/cancers14194816"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"100416","DOI":"10.1016\/j.jbo.2022.100416","article-title":"Experience with Denosumab (XGEVA\u00ae) for Prevention of Skeletal-Related Events in the 10 Years after Approval","volume":"33","author":"Cadieux","year":"2022","journal-title":"J. Bone Oncol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1345\/aph.1M102","article-title":"Denosumab in Osteoporosis and Oncology","volume":"43","author":"Burkiewicz","year":"2009","journal-title":"Ann. Pharmacother."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jbmr\/zjae023","article-title":"Temporal Patterns of Osteoclast Formation and Activity Following Withdrawal of RANKL Inhibition","volume":"39","author":"Kim","year":"2024","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"ref_184","first-page":"1020","article-title":"Denosumab Use Reduces Risk of Rheumatoid Arthritis in Patients with Osteoporosis","volume":"42","author":"Chen","year":"2024","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.3390\/curroncol31040160","article-title":"The Evaluation and Management of Lung Metastases in Patients with Giant Cell Tumors of Bone in the Denosumab Era","volume":"31","author":"Trovarelli","year":"2024","journal-title":"Curr. Oncol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1158\/2326-6066.CIR-23-0184","article-title":"Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with Cancer","volume":"12","author":"Chang","year":"2024","journal-title":"Cancer Immunol. Res."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1470-2045(18)30862-3","article-title":"Adjuvant Denosumab in Postmenopausal Patients with Hormone Receptor-Positive Breast Cancer (ABCSG-18): Disease-Free Survival Results from a Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial","volume":"20","author":"Gnant","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/s41416-018-0225-4","article-title":"Denosumab and Breast Cancer Risk in Postmenopausal Women: A Population-Based Cohort Study","volume":"119","author":"Giannakeas","year":"2018","journal-title":"Br. J. Cancer"},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Lu, J., Hu, D., Zhang, Y., Ma, C., Shen, L., and Shuai, B. (2023). Current Comprehensive Understanding of Denosumab (the RANKL Neutralizing Antibody) in the Treatment of Bone Metastasis of Malignant Tumors, Including Pharmacological Mechanism and Clinical Trials. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1133828"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","article-title":"Randomized, Double-Blind Study of Denosumab versus Zoledronic Acid in the Treatment of Bone Metastases in Patients with Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma","volume":"29","author":"Henry","year":"2011","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Bonnelye, E., and Ju\u00e1rez, P. (2021). Targeting Bone Metastasis in Cancers. Cancers, 13.","DOI":"10.3390\/cancers13174490"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S1470-2045(18)30072-X","article-title":"Denosumab versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Double-Dummy, Randomised, Controlled, Phase 3 Study","volume":"19","author":"Raje","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S1470-2045(19)30687-4","article-title":"Adjuvant Denosumab in Early Breast Cancer (D-CARE): An International, Multicentre, Randomised, Controlled, Phase 3 Trial","volume":"21","author":"Coleman","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"11795549231182266","DOI":"10.1177\/11795549231182266","article-title":"A Retrospective Analysis of Denosumab for the Treatment of Bone Metastases in Chinese Patients with Breast Cancer","volume":"17","author":"Li","year":"2023","journal-title":"Clin. Med. Insights Oncol."},{"key":"ref_195","first-page":"259","article-title":"Efficacy and Safety of Denosumab Biosimilar QL1206 Versus Denosumab in Patients with Bone Metastases from Solid Tumors: A Randomized Phase III Trial","volume":"37","author":"Li","year":"2023","journal-title":"BioDrugs Clin. Immunother. Biopharm. Gene Ther."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/intimm\/dxz009","article-title":"Anti-Receptor Activator of Nuclear Factor \u03baB Ligand Antibody Treatment Increases Osteoclastogenesis-Promoting IL-8 in Patients with Rheumatoid Arthritis","volume":"31","author":"Morita","year":"2019","journal-title":"Int. Immunol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1200\/JCO.23.00980","article-title":"Canakinumab Versus Placebo in Combination with First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial","volume":"42","author":"Tan","year":"2024","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_198","first-page":"E4","article-title":"Successful Treatment of SAPHO Syndrome (Chronic Nonbacterial Osteomyelitis and Acne) with Anakinra and Denosumab. Case Report and Review of Therapy","volume":"69","author":"Adam","year":"2023","journal-title":"Vnit\u0159. L\u00e9ka\u0159stv\u00ed"},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Singh, K.B., Rai, R., Khanka, S., and Singh, D. (2022). Discontinuation of PTH Therapy Amplifies Bone Loss by Increasing Oxidative Stress: An Event Ameliorated by Sequential IL-17 Neutralizing Antibody Therapy. Biomed. Pharmacother., 145.","DOI":"10.1016\/j.biopha.2021.112390"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12962-024-00522-7","article-title":"Cost-Consequence Analysis of Tocilizumab versus Adalimumab and Etanercept among Rheumatoid Arthritis Patients in Saudi Arabia: A Single-Center Study","volume":"22","author":"Albahdal","year":"2024","journal-title":"Cost Eff. Resour. Alloc. CE"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s41669-023-00426-x","article-title":"Cost-Effectiveness Analysis of Siltuximab for Australian Public Investment in the Rare Condition Idiopathic Multicentric Castleman Disease","volume":"7","author":"Shupo","year":"2023","journal-title":"PharmacoEconomics-Open"},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Kartikasari, A.E.R., Huertas, C.S., Mitchell, A., and Plebanski, M. (2021). Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.692142"},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Iuliani, M., Simonetti, S., Ribelli, G., Napolitano, A., Pantano, F., Vincenzi, B., Tonini, G., and Santini, D. (2020). Current and Emerging Biomarkers Predicting Bone Metastasis Development. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.00789"},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Hao, Y., Zhang, F., Ma, Y., Luo, Y., Zhang, Y., Yang, N., Liu, M., Liu, H., and Li, J. (2023). Potential Biomarkers for the Early Detection of Bone Metastases. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1188357"},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Wu, H., Yang, J., Yuan, L., Tan, Z., Zhang, X., Hambly, B.D., Bao, S., and Tao, K. (2024). IL-38 Promotes the Development of Prostate Cancer. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1384416"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.7150\/ijms.90642","article-title":"Interleukin-25 as a Potential Biomarker in Lung Metastasis of Hepatocellular Carcinoma with HBV History in Chinese Patients: A Single Center, Case-Control Study","volume":"21","author":"Liao","year":"2024","journal-title":"Int. J. Med. Sci."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"e38091","DOI":"10.1097\/MD.0000000000038091","article-title":"IL-6 Significantly Correlated with the Prognosis in Low-Grade Glioma and the Mediating Effect of Immune Microenvironment","volume":"103","author":"Yang","year":"2024","journal-title":"Medicine"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"156595","DOI":"10.1016\/j.cyto.2024.156595","article-title":"Low Expression of Interleukin-1 Receptor Antagonist Correlates with Poor Prognosis via Promoting Proliferation and Migration and Inhibiting Apoptosis in Oral Squamous Cell Carcinoma","volume":"179","author":"Ding","year":"2024","journal-title":"Cytokine"},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Albuquerque, R.B., Borba, M.A.S.M., Fernandes, M.S.S., Filgueira, T.O., Martins, D.B.G., Filho, J.L.L., Castoldi, A., and Souto, F.O. (2023). Interleukin-33 Expression on Treatment Outcomes and Prognosis in Brazilian Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242216326"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s10147-024-02477-4","article-title":"MMP1, IL-1\u03b2, sTNFR-1, and IL-6 Are Prognostic Factors for Patients with Unresectable or Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors","volume":"29","author":"Nagasaka","year":"2024","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-3835(01)00524-9","article-title":"Interleukins-6 and -11 Expression in Primary Breast Cancer and Subsequent Development of Bone Metastases","volume":"169","author":"Sotiriou","year":"2001","journal-title":"Cancer Lett."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"100374","DOI":"10.1016\/j.jbo.2021.100374","article-title":"A Predictive Biomarker Panel for Bone Metastases: Liquid Biopsy Approach","volume":"29","author":"Bhadresha","year":"2021","journal-title":"J. Bone Oncol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jpainsymman.2022.06.018","article-title":"Inflammatory Markers and Radiotherapy Response in Patients with Painful Bone Metastases","volume":"64","author":"Habberstad","year":"2022","journal-title":"J. Pain Symptom Manag."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/15\/8163\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:24:15Z","timestamp":1760109855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/15\/8163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,26]]},"references-count":213,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["ijms25158163"],"URL":"https:\/\/doi.org\/10.3390\/ijms25158163","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,26]]}}}